FDA Plays

[colorofmoney]

PSID NEWS...Co announces that it has achieved an important milestone in the development of its non-invasive Easy Check breath glucose detection system. The co has completed the development of a single-use capsule containing a proprietary chemical reagent that it believes will enable it to accelerate its development schedule and produce a lab-scale prototype device during 3Q10. The prototype is expected to be able to measure the levels of acetone in a patient's exhaled breath, which, in turn, will be translated into a measurement of blood glucose levels, which could eliminate a patient's need to prick his or her finger multiple times per day to get a blood sugar reading.